skip to main content

News Archive

Date: 04/21/2023
Michelle Kim, M.D., associate professor of radiation oncology at Michigan Medicine, has received a Research Specialist Award from the National Cancer Institute to pursue clinical research efforts at the University of Michigan Rogel Cancer Center and nationally. Kim’s focus is on clinical research for central nervous system (CNS) tumors.
Date: 04/20/2023
A team from the University of Michigan Rogel Cancer Center and School of Dentistry, led by Yu Leo Lei, D.D.S., Ph.D., have identified a mechanism in mice for how obesity affects some oral cancers’ ability to escape from the immune system.
Date: 04/17/2023
A study from University of Michigan Rogel Cancer Center researchers surveyed the partners of colorectal cancer patients and found the financial impact of a loved one’s diagnosis also impacts the partner’s health-related quality of life.
Date: 04/17/2023
In a study involving 30 pancreata from donors with no known gastrointestinal disease, researchers found precancerous lesions called pancreatic intraepithelial neoplasia in the majority of the organs. They also discovered that the lesions bore a similar gene expression signature to that of pancreatic cancer. These findings upend conventional wisdom that all PanIN are necessarily precursors to pancreatic cancer; given that the incidence of pancreatic cancer is relatively low, it’s not likely that all (or any) of the lesions are indicators of future cancer.
Date: 04/14/2023
Researchers at the U-M Rogel Cancer Center created a standardized metric for nerve density to clarify the variation in distribution of nerves in the oral cavity, called normalized nerve density, and showed its importance in oral cancer tumor progression.
Date: 04/12/2023
Barriers to genetic testing for patients with cancer may vary based on demographics and other personal factors, a pilot project associated with a large clinical trial found. In a University of Michigan study, women, for instance, were more likely to report worries about the implications of their test results for family members and how their results could affect their health and life insurance.
Date: 04/11/2023
After years in the shadow of more common cancers, there’s new light for patients with thyroid cancer. Increased use of neck ultrasounds has driven up the number of people globally who are diagnosed with thyroid cancer, which has brought new attention to the disease. It’s now the ninth most common cancer worldwide.
Date: 04/11/2023
Rogel Cancer Center faculty and trainees will lead over two dozen presentations, posters and moderated sessions at the American Association for Cancer Research annual meeting. This year’s meeting will be held in-person. View the schedule of presentations.
Date: 04/04/2023
To understand the molecular processes that influence how cancer cells pass through the blood-brain barrier, Dr. Sofia Merajver and colleagues used two microfluidic chips that mapped cancer cell migration to the brain and looked at what was happening in the blood-brain niche.
Date: 04/03/2023
The Rogel Cancer Center is partnering with the Institute for Healthcare Policy and Innovation to help teams translate research into policy. The collaboration offers a cancer-specific opportunity under IHPI’s Policy Sprints program, which launched in 2018 to provide policymakers and stakeholders with timely and rigorous evidence to inform health policy or practice at the local, state, national, or global levels.